Actively Recruiting
Comparison of Topical Insulin and Amniotic Membrane Transplant for Persistent Corneal Epithelial Defects
Led by Al-Shifa Trust Eye Hospital · Updated on 2026-05-01
214
Participants Needed
1
Research Sites
26 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
After an initial period of standard treatment, they received further care aimed at helping the surface of the eye heal. Clear instructions were given on how to use and store the treatment properly. Patients were then monitored regularly over several months, with doctors checking their healing progress during follow-up visits. The study continued for a total of 24 weeks to observe how well and how quickly the eye surface recovered.
CONDITIONS
Official Title
Comparison of Topical Insulin and Amniotic Membrane Transplant for Persistent Corneal Epithelial Defects
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Corneal epithelial defects lasting more than 2 weeks without improvement after standard treatment
You will not qualify if you...
- Uncontrolled diabetes or autoimmune disorders
- Eye surgery within the last 3 months
- Hereditary corneal dystrophies
- Active eye infections
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Al Shifa Eye Trust Hospital
Rawalpindi, Punjab Province, Pakistan, 46000
Actively Recruiting
Research Team
S
Subha Mashaam Principal Investigator, MBBS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here